Deciphera Pharmaceuticals, Inc. logo

Deciphera Pharmaceuticals, Inc. Share Price Today (NASDAQ: DCPH)

Deciphera Pharmaceuticals, Inc. share price is $0 & ₹0.00 as on 9 Jun 2024 IST

▲

-25.59

(-100%)

Market is closed - opens 7 PM, 09 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 10 Jun 2024

View live Deciphera Pharmaceuticals, Inc. share price in Dollar and Rupees. Guide to invest in Deciphera Pharmaceuticals, Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Deciphera Pharmaceuticals, Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Deciphera Pharmaceuticals, Inc. (DCPH) Key Statistics

in dollars & INR

Previous Close
$25.59
Open
$25.56
Market Capitalization
$2.2B
Today's Volume
$1.6M
Revenue TTM
$174.9M
EBITDA
$-204.6M
Earnings Per Share (EPS)
$-2.21
Profit Margin
-108.87%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-50.37%

How to invest in Deciphera Pharmaceuticals, Inc. Stock (DCPH) from India?

It is very easy for Indian residents to invest directly in Deciphera Pharmaceuticals, Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Deciphera Pharmaceuticals, Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Deciphera Pharmaceuticals, Inc. or DCPH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Deciphera Pharmaceuticals, Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Deciphera Pharmaceuticals, Inc. shares which would translate to null fractional shares of Deciphera Pharmaceuticals, Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Deciphera Pharmaceuticals, Inc., in just a few clicks!

Global Institutional Holdings in Deciphera Pharmaceuticals, Inc.

  • BlackRock Inc

    6.93%

  • Armistice Capital, LLC

    6.82%

  • Redmile Group, LLC

    6.13%

  • Deerfield Management Co

    5.93%

  • Vanguard Group Inc

    5.28%

  • State Street Corporation

    3.58%

Analyst Recommendation on Deciphera Pharmaceuticals, Inc.

Rating
Trend

Buy

    50%Buy

    50%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Deciphera Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

About Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.
Organization
Deciphera Pharmaceuticals, Inc.
Employees
355
CEO
Mr. Steven L. Hoerter
Industry
Health Technology

Important FAQs about investing in DCPH Stock from India :

Can Indians buy Deciphera Pharmaceuticals, Inc. shares?

Yes, Indians can invest in the Deciphera Pharmaceuticals, Inc. (DCPH) from India.

With INDmoney, you can buy Deciphera Pharmaceuticals, Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Deciphera Pharmaceuticals, Inc. at zero transaction cost.

How can I buy Deciphera Pharmaceuticals, Inc. shares from India?

It is very easy to buy Deciphera Pharmaceuticals, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Deciphera Pharmaceuticals, Inc. (DCPH) be purchased?

Yes, you can buy fractional shares of Deciphera Pharmaceuticals, Inc. with INDmoney app.

What are the documents required to start investing in Deciphera Pharmaceuticals, Inc. stocks?

To start investing in Deciphera Pharmaceuticals, Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Deciphera Pharmaceuticals, Inc.?

Today's market capitalisation of Deciphera Pharmaceuticals, Inc. DCPH is 2.2B

Who is the Chief Executive Officer (CEO) of Deciphera Pharmaceuticals, Inc. ?

Mr. Steven L. Hoerter is the current Chief Executive Officer (CEO) of Deciphera Pharmaceuticals, Inc..